Quarterly report · Q2

Period2023-01-01 → 2023-06-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed

Amends S100RP7J.

Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥1.3bn2023-01-01 → 2023-06-30Cons.Net sales
Revenue¥2.3bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥1.2bn2022-01-01 → 2022-06-30Cons.Net sales
Operating income¥217m2023-01-01 → 2023-06-30Cons.Operating income
Operating income¥315m2022-01-01 → 2022-06-30Cons.Operating income
Ordinary income¥213m2023-01-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥346m2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥294m2022-01-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥219m2023-01-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥343m2022-01-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥158m2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥265m2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥226m2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥158m2023-01-01 → 2023-06-30Cons.Profit loss
Net income¥226m2022-01-01 → 2022-06-30Cons.Profit loss
Total assets¥1.5bnat 2023-06-30Cons.Assets
Total assets¥1.3bnat 2022-12-31Cons.Assets
Total assets¥1.2bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥631mat 2023-06-30Cons.Liabilities
Total liabilities¥641mat 2022-12-31Cons.Liabilities
Net assets / equity¥823mat 2023-06-30Cons.Net assets
Net assets / equity¥655mat 2022-12-31Cons.Net assets
Net assets / equity¥616mat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥812mat 2023-06-30Cons.Cash and deposits
Cash and deposits¥660mat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥812mat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥660mat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥829mat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥423mat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow−¥18m2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥377m2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥285m2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥38m2023-01-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥260m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥25m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥209m2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥119m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥146m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥162023-01-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥6.122023-04-01 → 2023-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.192022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.342022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.592022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥14.962023-01-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥25.132022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥21.722022-01-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio56.6%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio50.5%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio52.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 48
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-06-30¥147m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-06-30¥147m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-06-30−¥200m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-06-30−¥200m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥10m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥84m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥31m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥52m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥36m
jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥242m
jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥242m
jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥118m
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥1.0bn
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥1.0bn
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥450,000
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥72m
—segment totalrevenue2023-01-01 → 2023-06-30¥1.4bn
—segment totalrevenue external2023-01-01 → 2023-06-30¥1.3bn
—segment totalrevenue intersegment2023-01-01 → 2023-06-30¥53m
—segment totalsegment profit2023-01-01 → 2023-06-30¥227m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-06-30¥1.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-01-01 → 2023-06-30¥200m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-06-30¥227m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-06-30¥100m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-06-30¥100m
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-06-30−¥125m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-06-30−¥125m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥25m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥54m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥30m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥24m
jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥558,000
jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥435m
jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥435m
jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥244m
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥715m
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥715m
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥500,000
jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥97m
—segment totalrevenue2022-01-01 → 2022-06-30¥1.2bn
—segment totalrevenue external2022-01-01 → 2022-06-30¥1.2bn
—segment totalrevenue intersegment2022-01-01 → 2022-06-30¥24m
—segment totalsegment profit2022-01-01 → 2022-06-30¥340m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-06-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-01-01 → 2022-06-30¥125m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-06-30¥340m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 510
ItemContextValueUnit
Net cash provided by used in investment activitiesPrior1YTDDuration-24844000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-37717000JPY
Net increase decrease in short term loans payable fin cfPrior1YTDDuration-JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration44668000JPY
Proceeds from long term borrowings fin cfPrior1YTDDuration100000000JPY
Proceeds from long term borrowings fin cfCurrentYTDDuration222333000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-71225000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-66418000JPY
Proceeds from issuance of common stock fin cfPrior1YTDDuration135924000JPY
Proceeds from issuance of common stock fin cfCurrentYTDDuration9900000JPY
Repayments of lease obligations fin cfPrior1YTDDuration-6420000JPY
Repayments of lease obligations fin cfCurrentYTDDuration-1705000JPY
Payment of listing expenses fin cfPrior1YTDDuration-10898000JPY
Payment of listing expenses fin cfCurrentYTDDuration-JPY
Payments from issuance of share acquisition rights fin cfPrior1YTDDuration-1563000JPY
Payments from issuance of share acquisition rights fin cfCurrentYTDDuration-36000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration145817000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration208740000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration-JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration-JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration405802000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration152573000JPY
Cash and cash equivalentsPrior2YearInstant423499000JPY
Cash and cash equivalentsPrior1YearInstant659511000JPY
Cash and cash equivalentsPrior1QuarterInstant829302000JPY
Cash and cash equivalentsCurrentQuarterInstant812084000JPY
Salaries and allowances sgaPrior1YTDDuration131049000JPY
Salaries and allowances sgaCurrentYTDDuration193234000JPY
Expenses for recruiting doctors and others sgaPrior1YTDDuration125240000JPY
Expenses for recruiting doctors and others sgaCurrentYTDDuration58459000JPY
Advertising expenses sgaPrior1YTDDuration43622000JPY
Advertising expenses sgaCurrentYTDDuration73070000JPY
Legal welfare expenses sgaPrior1YTDDuration20006000JPY
Legal welfare expenses sgaCurrentYTDDuration30827000JPY
Directors compensations sgaPrior1YTDDuration18876000JPY
Directors compensations sgaCurrentYTDDuration17080000JPY
Commission fee sgaPrior1YTDDuration18202000JPY
Commission fee sgaCurrentYTDDuration33302000JPY
Recruiting expenses sgaPrior1YTDDuration14912000JPY
Recruiting expenses sgaCurrentYTDDuration18494000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E37508-000MentalHealthSolutionBusinessReportableSegmentsMember714595000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E37508-000MedicalCareerSupportBusinessReportableSegmentsMember434931000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E37508-000DigitalMarketingBusinessReportableSegmentsMember30215000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember1179742000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1179742000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration1179742000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E37508-000MentalHealthSolutionBusinessReportableSegmentsMember500000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E37508-000MedicalCareerSupportBusinessReportableSegmentsMember-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass